The meta-analysis of all clinical studies has shown that decreased PP13 in maternal blood starts at 6 to 8 weeks of gestation and extends throughout the first trimester in women who will subsequently develop preeclampsia [7], [16], [25]. The gene discussed is LGALS13; the disease is preeclampsia.